
Alphatec Hlds (ATEC) Stock Forecast & Price Target
Alphatec Hlds (ATEC) Analyst Ratings
Bulls say
Alphatec Holdings Inc. anticipates total revenues of $890 million for 2026, indicating a robust 17% increase over preliminary 2025 estimates, supported by positive surgeon survey feedback that highlights it as a leading share gainer. The company's performance metrics reveal notable growth, with new surgeon adoption increasing by 26% and established territory revenue accelerating by 30%, contributing to a sustained year-over-year surgical volume increase of 28%. Additionally, the company exceeded expectations with an adjusted EBITDA of $26 million, surpassing estimates and reflecting improving margins and free cash flow durability, which underscores the strong financial trajectory of Alphatec Holdings.
Bears say
Alphatec Holdings has indicated a bearish outlook due to concerns surrounding lower-than-expected revenue growth in the U.S. market and reduced free cash flow projections. Key metrics reveal a forecasted revenue drop correlated with a modest sequential growth expectation of only 10% from 3Q25 to 4Q25, compared to a stronger prior period growth of 14%. Additionally, several risks, including sales execution challenges and competition in the spine market, contribute to the negative sentiment surrounding the company's financial stability and future performance.
This aggregate rating is based on analysts' research of Alphatec Hlds and is not a guaranteed prediction by Public.com or investment advice.
Alphatec Hlds (ATEC) Analyst Forecast & Price Prediction
Start investing in Alphatec Hlds (ATEC)
Order type
Buy in
Order amount
Est. shares
0 shares